A U.S. and Canada study shows that ASA 300 mg daily does not improve risk of breast cancer recurrence or survival in individuals with high-risk nonmetastatic breast cancer.
‘Of course, we get all these patients, where the GP has completely missed all those symptoms,’ I heard a specialist say. Needless to say, I was fuming.